Discovery Enters Phase II Trial Of Surfaxin For Acute Respiratory Failure In Children
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm takes next step in its goal to develop compound for wide range of respiratory problems in children and adults.
You may also be interested in...
Discovery Finalizing Surfaxin “Complete Response,” Eyes 2008 Approval
Firm plans response to May 1 “approvable” letter that addresses biological activity test criteria, lipid-related impurities.
Discovery Finalizing Surfaxin “Complete Response,” Eyes 2008 Approval
Firm plans response to May 1 “approvable” letter that addresses biological activity test criteria, lipid-related impurities.
Discovery Labs Anticipates Surfaxin Approval In 2008 For Respiratory Distress Syndrome
Firm is resolving outstanding manufacturing issues with the synthetic surfactant, with plans to submit six-month stability data in a “complete response” to FDA.